ALF-202

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameALF-202
Drug Alias Name异体内皮祖细胞（EPCs）ALF-202
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Allife Medicine Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChengnuo Regenerative Medicine Technology (Beijing) Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A